PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...
China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...
Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Institut P...
The limitations of the existing drug discovery paradigm reveals that there are still no effective prevention or real cur...
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel target...
Pfizer Inc. has announced an agreement with the US government to supply 10 million treatment courses of its investi...
Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...
SuperTrans Medical ("STM"), an Australian biopharmaceutical company developing novel antibiotics that target difficult-t...
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collabo...
French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...
